Home > Insider Trading > Filing (0001209191-13-010670)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1340652	Chemocentryx Inc.	CCXI	Pharmaceutical Preparations (2834)	943254365

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1422996	C. Juan Jaen	C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043	Svp, Drug Discovery & Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-02-19	6,800	$4.30	59,800	No	4	M	Direct
Common Stock	Disposition	2013-02-19	6,800	$11.86	53,000	No	4	S	Direct
Common Stock	Acquisiton	2013-02-19	700	$4.30	53,700	No	4	M	Direct
Common Stock	Disposition	2013-02-19	700	$11.85	53,000	No	4	S	Direct
Common Stock	Disposition	2013-02-19	8,000	$11.95	45,000	No	4	S	Direct
Common Stock	Acquisiton	2013-02-20	5,601	$4.30	50,601	No	4	M	Direct
Common Stock	Disposition	2013-02-20	5,601	$11.90	45,000	No	4	S	Direct
Common Stock	Acquisiton	2013-02-21	1,100	$4.30	46,100	No	4	M	Direct
Common Stock	Disposition	2013-02-21	1,100	$11.89	45,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2013-02-19	6,800	$0.00	6,800	$4.30
Common Stock	Employee Stock Option (right to buy)	Disposition	2013-02-19	700	$0.00	700	$4.30
Common Stock	Employee Stock Option (right to buy)	Disposition	2013-02-20	5,601	$0.00	5,601	$4.30
Common Stock	Employee Stock Option (right to buy)	Disposition	2013-02-21	1,100	$0.00	1,100	$4.30

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
140,000	2017-02-06	No	4	M	Direct
139,300	2017-02-06	No	4	M	Direct
133,699	2017-02-06	No	4	M	Direct
132,599	2017-02-06	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $11.80 to $11.98 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $11.85 to $11.95 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $11.85 to $11.90 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
As of February 19, 2013 and prior to this transaction, the option fully vested.
Not applicable.